Export Manufacturing Waiver for Supplementary Protection Certificates: a red flag for investment in EU healthcare biotech

As the Association representing the European biotechnology industry, EuropaBio is fully committed to the development of a legislative environment which facilitates the creation of EU jobs and growth as well as new solutions to healthcare challenges.

SPC waiver risks downgrading the EU as a hub for Health Innovation

As an association that has manufacturers of both originator and biosimilar medicines as members, EuropaBio strongly doubts that the promises of today’s Commission proposal outweigh the risks of losing investment in new medicines.